Cargando…
Design, Synthesis and Evaluation of New Bioactive Oxadiazole Derivatives as Anticancer Agents Targeting Bcl-2
A series of 2-(1H-indol-3-yl)-5-substituted-1,3,4-oxadiazoles, 4a–m, were designed, synthesized and tested in vitro as potential pro-apoptotic Bcl-2 inhibitory anticancer agents based on our previously reported hit compounds. Synthesis of the target 1,3,4-oxadiazoles was readily accomplished through...
Autores principales: | Hamdy, Rania, Elseginy, Samia A., Ziedan, Noha I., El-Sadek, Mohamed, Lashin, Elsaid, Jones, Arwyn T., Westwell, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730549/ https://www.ncbi.nlm.nih.gov/pubmed/33256166 http://dx.doi.org/10.3390/ijms21238980 |
Ejemplares similares
-
New Quinoline-Based Heterocycles as Anticancer Agents Targeting Bcl-2
por: Hamdy, Rania, et al.
Publicado: (2019) -
New Bioactive Fused Triazolothiadiazoles as Bcl-2-Targeted Anticancer Agents
por: Hamdy, Rania, et al.
Publicado: (2021) -
Design, Synthesis, and Potent Anticancer Activity of Novel Indole-Based Bcl-2 Inhibitors
por: Almehdi, Ahmed M., et al.
Publicado: (2023) -
Synthesis, Characterization, and Antimicrobial Evaluation of Oxadiazole Congeners
por: Sadek, Bassem, et al.
Publicado: (2011) -
Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9
por: Özdemir, Ahmet, et al.
Publicado: (2017)